CIBC Bancorp USA’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
Other funds holding DXCM
CIBC Bancorp USA's DXCM Position: Q3 2026 in Review
CIBC Bancorp USA reduced its DexCom (DXCM) stake by 8.4% in Q3 2026, selling an estimated $24M and leaving 3,165,935 shares worth $273M. The position accounts for 0.34% of the portfolio, ranked #65.
CIBC Bancorp USA first reported a position in DXCM in Q3 2025 and has held it in 4 quarters since. 1,043 funds tracked by Wall St. Rank hold DXCM as of Q3 2026.
- CIBC Bancorp USA held 3,165,935 shares of DexCom worth $273M as of Q3 2026.
- CIBC Bancorp USA sold 288,800 DexCom shares in Q3 2026, an estimated $24M.
- DexCom made up 0.34% of CIBC Bancorp USA's portfolio in Q3 2026, its #65 holding.
- CIBC Bancorp USA first reported a position in DexCom in Q3 2025 and has held it in 4 quarters since.
- 1,043 funds tracked by Wall St. Rank held DexCom as of Q3 2026.
Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.